News

BioBridge offers a variety of ways for you to stay connected with us. You can read our latest press releases or the Annual Reports. Visit the Events Page to find out what’s coming up. You can watch a video clip from a newscast, view past events in the Photo Gallery or read industry news. For the Social Media enthusiast, BioBridge Global is known as “Connect for Life,” and can be found on FacebookTwitterLinkedIn and YouTube. Also visit the official BioBridge Global blog here.

Media is welcome to contact the Corporate Communications Department for more information. We offer:

  • 
Interviews with experts in their respective medical fields
  • Interviews with Life Links - community members touched by the services of BioBridge Global
  • Informative tours of the facility
Please contact: 
Corporate Communications
Phone: (210) 731-5519
Mobile: (210) 296-9026
Email: crd@biobridgeglobal.org
 

Recent News Articles

Community blood center offering test over summer to thank donors
June 6, 2020

To thank donors for coming out to give, the South Texas Blood & Tissue Center (STBTC) will provide free COVID-19 antibody testing for all blood donations this summer, from June 8 - Aug. 31. Test results will be mailed to donors within 14 days of their donations, which are by appointment only.

QualTex Laboratories, which like STBTC is a subsidiary of San Antonio-based nonprofit BioBridge Global, will perform the tests. Results will show if the donor has been exposed to the virus that causes COVID-19 by looking for antibodies the immune system produces in response to the virus.

Each blood donation matched with financial gift to local food bank; South Texas Blood & Tissue Center must make up 4,000-donation summer deficit
May 17, 2020

stbtc_alamodome_bannerBlood donors can do twice the good with one selfless act at the upcoming “Double Down in SA Town” drive at the Alamodome on May 21-23, helping fight the severe impact COVID-19 has had on both the community blood supply and on food available for hungry families.

The need for blood donations has grown significantly as hospitals in the region resume non-emergency surgeries and other procedures delayed because of the coronavirus outbreak. At the same time, more than 120 blood drives, representing more than 4,000 donations, already have been canceled this summer.

May 14, 2020

The South Texas Blood & Tissue Center’s program providing plasma transfusions for COVID-19 patients is a good example of what COO Elizabeth Waltman calls “big medicine.” 

“This is big medicine – this is why community blood centers are so important,” she told members of The Blood & Tissue Center Foundation’s board of directors at their quarterly meeting on May 11. “No pharmaceutical company, no plasma center, no one could do what we did in four days.” 

Waltman encouraged anyone who had been diagnosed with and recovered from COVID-19 to email STBTC at COVID19@southtexasblood.org about participating in what is known as the “convalescent plasma” program. 

Community asked to make and keep appointments to donate blood
May 7, 2020
blood_donations_needed

As South Texas hospitals begin to reschedule postponed surgeries, the South Texas Blood & Tissue Center (STBTC) is asking members of the community to come forward with lifesaving blood donations and to keep their appointments.

The South Texas Blood & Tissue Center, a subsidiary of San Antonio-based BioBridge Global, already is seeing a significant increase in orders for blood following Gov. Greg Abbott’s order for hospitals to resume elective surgeries and procedures.

The center estimates it needs 500 donors a day to keep up with demand.

“Right now, we are sending out 150 more units of blood every day than we’re bringing in,” said Elizabeth Waltman, Chief Operating Officer of STBTC. “Our community has always responded in times of need and we hope they will continue to answer the call caused by this pandemic.”

Test to identify antibody levels developed in partnership with XBiotech
April 3, 2020

The South Texas Blood & Tissue Center, a subsidiary of San Antonio-based BioBridge Global, is participating in a U.S. Food and Drug Administration (FDA) investigational program for U.S. blood centers to begin collecting and distributing convalescent plasma from individuals who have recovered from COVID-19.

While COVID-19 currently has no proven treatment, it is possible that convalescent plasma, which contains antibodies to the virus that causes COVID-19, may provide passive immunity to certain patients with severe forms of the illness. Plasma is the liquid component of the bloodstream, and it includes the disease-fighting antibodies that a body produces in response to an infection.

Pages